Hyperhidrosis. Primary focal hyperhidrosis, axilla
Conditions
Interventions
Intervention 1: Intervention group: All participants were instructed to shave their underarm hair and to refrain from using any antiperspirants, deodorants, or topical products in the axillary area fo
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Patients with hyperhidrosis confirmed by a dermatologist Patients aged between 18 and 50 years With a disease severity score greater than 2 based on the Hyperhidrosis Disease Severity Scale (HDSS) The condition must be bilateral
Exclusion criteria
Exclusion criteria: Women who are pregnant or breastfeeding Previous treatments with botulinum toxin injections Thermolysis performed using microwave energy Use of any medication that may affect the study outcomes (such as anticholinergics, aminoglycosides, or calcium channel blockers). History of any skin allergy to topical agents
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of hyperhidrosis. Timepoint: Before the start of the study and at weeks 4, 6, and 8 (i.e., two weeks after discontinuation of the medication). Method of measurement: Hyperhidrosis Disease Severity Scale.;Quality of life of dermatology patients. Timepoint: At the beginning and end of the study. Method of measurement: Dermatology Life Quality Index (DLQI). | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of sweating rate. Timepoint: At the beginning and end of the study. Method of measurement: Gravimetric test and Iodine-starch test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mohammad Mahdi Parvizi
Shiraz University of Medical Sciences
Outcome results
None listed